Abstract
Adenotomy ranks among the most frequently performed procedures in otorhinolaryngology in the pediatric population. Although it is regarded as a relatively straightforward and highly effective surgical intervention, adenotomy carries a well-recognized risk of adenoid recurrence. The precise etiological factors underlying recurrence, as well as the associated risk determinants, have not yet been fully established The aim of the study was to evaluate the outcomes of surgical treatment of adenoid disease in the pediatric population and to identify the risk factors associated with postoperative recurrence. Materials and Methods. A total of 112 children aged 2–15 years who had undergone adenotomy were enrolled in the study. A structured parental survey was administered to assess the primary symptoms of adenoid hypertrophy and their dynamics following surgery. In 56 children, follow-up evaluation was performed, encompassing nasal endoscopy of the nasopharynx and ears, tympanometry, and measurement of total immunoglobulin E (IgE), as well as immunoglobulin M (IgM) and immunoglobulin G (IgG) directed against the Epstein–Barr virus capsid antigen. Risk factors for adenoid recurrence were assessed by calculating the odds ratio (OR). The study was conducted in compliance with established bioethical standards and received approval from the Bioethics Committee of Bukovinian State Medical University. Statistical analysis was performed using Statistica 6 and BIOSTAT software. Quantitative data were processed by means of variational statistical analysis. Binary parameters, expressed as "−" and "+", were analyzed using Fisher's exact test for 2×2 and 4×4 contingency tables, as well as Fisher's angular transformation (φ) following conversion of absolute values to percentages. The role of each studied indicator as a potential risk marker was evaluated using clinical epidemiology methods. OR and 95% confidence intervals (CI) were calculated for each factor. A factor was considered clinically significant if OR exceeded 1.2; an OR below 0.8 was interpreted as indicative of a clinically significant protective effect. This study constitutes part of a planned comprehensive research project of the Department of Pediatric Surgery, Otolaryngology, and Ophthalmology at Bukovinian State Medical University, entitled "Clinical and Pathogenetic Rationale for the Correction of the Functional State of Certain Homeostatic Systems in Patients in Specific Sections of Surgical Practice and Intensive Care" (state registration number 0125U002045). Results. The predominant preoperative complaints in the study group included persistent nasal breathing difficulty (77.6%), nocturnal snoring (77.6%), adenoid facies (19.6%), conductive hearing loss (50.9%), recurrent acute suppurative otitis media (24.1%), and recurrent acute bacterial tonsillitis (39.3%). Following adenotomy, nasal breathing was restored in 80.4% of patients, nocturnal snoring resolved in 77.7%, hearing was restored in 90.2%, the frequency of acute suppurative otitis media episodes was reduced in 69.6%, and the frequency of acute bacterial tonsillitis episodes decreased accordingly. Follow-up examination of 56 children identified the following risk factors for adenoid recurrence: adenotomy performed at an early age (OR 2.7; 95% CI 0.85–8.69), elevated total IgE (OR 1.9; 95% CI 0.45–7.86), elevated IgM (OR 4.1; 95% CI 0.93–17.93) and IgG (OR 2.4; 95% CI 0.67–8.59) directed against the Epstein–Barr virus capsid antigen, periodic fever with aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome (OR 2.3; 95% CI 0.71–7.86), and recurrent acute bacterial tonsillitis (OR 1.9; 95% CI 0.45–7.86). Concurrent tonsillotomy was identified as a protective factor against adenoid recurrence (OR 0.2; 95% CI 0.11–0.69). Conclusions. Adenotomy effectively restores nasal breathing, resolves conductive hearing loss, and reduces the frequency of middle ear infections. The reported recurrence rate ranges from 7% to 28%. Clinically, however, the presence of residual lymphoid tissue in the nasopharynx is of secondary importance; the determining factor is the persistence of symptoms attributable to nasal obstruction. Identified risk factors for adenoid recurrence include young age at the time of primary surgery, a history of atopic disease, prior Epstein–Barr virus infection, PFAPA syndrome, and recurrent acute bacterial tonsillitis.

This publication has 26 references indexed in Scilit: